An evaluation of current shigellosis treatment

Bibliography

• Weekly Epidemiological Record Vaccine Research and Development. New Strategies for accelerating Shigella vaccine development. World Health Organization, Geneva, 14 March. (1997) 73–80.
   Google Scholar
• ••An excellent review on shigella vaccine.
   Google Scholar
• MATA LJ, GANGAROSA EJ, CACERAS A et al.: Epidemic Shiga bacillus dysentery in Central America. Etiologic investigations in Guatemala, 1969. J. Infect. Dis. (1970) 122:170–180.
   Google Scholar
• •An original report from Latin America.
   Google Scholar
• MUTANDA LN, KAVITA JN, WAMOLA IA: Patterns of Shigella species and serotypes in East Africa. East Afr. Med. J. (1979) 56:381–387.
   PubMedGoogle Scholar
• RAHAMAN MM, KHAN MM, AZIZ KMS et al.: An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J. Infect. Dis. (1975) 132:15–19.
   PubMed Web of Science ®Google Scholar
• •An early report of the Bangladesh shigellosis epidemic.
   Google Scholar
• KHAN M, SHAHIDULLAH M: Contrasting epidemiology of Shigella dysenteriae and Shigella flexneri, Dacca. Trans. R. Soc. Trop. Med. Hyg. (1980) 74:528–533.
   PubMedGoogle Scholar
• KHAN M, CURLIN GT, HUQ I: Epidemiology of Shigella dysenteriae type 1 infections in Dacca urban area. Trop. Geogr. Med. (1979) 31:213–223.
   PubMedGoogle Scholar
• STOLL BG, GLASS RI, HUQ MI et al: Epidemiological and clinical features of patients infected with Shigella who attended a diarrhoeal disease hospital in Bangladesh. J. Infect. Dis. (1982) 146:177–183.
   PubMed Web of Science ®Google Scholar
• ••An excellent article on Shigella spp.epidemiology.
   Google Scholar
• MATHAN VI, BHAT P, KAPADIA CR et al.: Epidemia dysentery caused by the Shiga bacillus in a Southern Indian village. Diarrhoeal Dis. Res. (1984) 2:27–32.
   PubMedGoogle Scholar
• VELAUTHAPILLAI K: Epidemiology and bacteriology of Shigella shiga dysentery. Sri Lankan Family Physician (1980) 5:98.
   Google Scholar
• •A report from Sri Lanka.
   Google Scholar
• SONNADARA DA: Shigella shiga dysentery in children. Sri Lankan Family Physician (1982) 5:110.
   Google Scholar
• REZVI SHERIFF MH: Lessons to learn from my Maldivian experience with the Shigella dysentery. Sri Lankan Family Physician (1982) 5:117.
   Google Scholar
• PAL SC: Epidemic bacillary dysentery in West Bengal. Lancet (1984) 1:1462.
   PubMed Web of Science ®Google Scholar
• •The original paper on an epidemic of shigellosis in West Bengal, India.
   Google Scholar
• BOSE R, NASHIPURI JN, SEN PK et al.: Epidemic of dysentery in West Bengal: clinicians' enigma. Lancet (1984) 2:1160.
   PubMed Web of Science ®Google Scholar
• •An important article on the use of nalidixic acid for shigellosis.
   Google Scholar
• SEN D, SENGUPTA PG, BHATTACHARYA SK et al.: Epidemic Shiga bacillus dysentery in Port Blair, Andaman and Nicobar Islands, India. Diam Dis. Res. (1986) 4:161.
   PubMedGoogle Scholar
• BARRETT CONNOR E, CONNOR JD: Extraintestinal manifestations of shigellosis. Am. J. Gastroenterol (1970) 53:234–245.
   PubMedGoogle Scholar
• ••An excellent review of the complications ofshigellosis.
   Google Scholar
• BHATTACHARYA SK, SINHA AK, SEN D et al.: Extraintestinal manifestations of Shigellosis during an epidemic of bacillary dysentery in Port Blair, Andaman & Nicobar Islands (India). J. Assoc. Physicians India (1988) 36(5):319–320.
   PubMedGoogle Scholar
• •Complications of shigellosis in India.
   Google Scholar
• RAHAMAN MM, ALAM AKMJ,ISLAM MR: Leukaemoid reaction, haemolytic anaemia and hyponatraemia in severe Shigella dysenteriae type 1 infection. Lancet (1974) 1:1004 (Letter).
   Google Scholar
• •Complications of shigellosis in Bangladesh.
   Google Scholar
• NELSON JD, KUSMIESZ H, JACKSON LH: Comparison of trimethoprim/sulfamethoxazole and ampicillin therapy for shigellosis inambulatory patients. J. Pediam (1976) 89:491.
   Google Scholar
• ROSS S, CONTRONI G, KHAN W: Resistance of shigellae to ampicillin and other antibiotic. Am. Med. Assoc. (1972) 221:45.
   PubMed Web of Science ®Google Scholar
• SEN D, DUTTA P, DEB BC, PAL SC: Nalidixic acid resistant Shigella dysenteriae type 1 in eastern India.Lancet (1988) 2:911.
   PubMedGoogle Scholar
• ••Drug resistance in Shigella spp.
   Google Scholar
• BHATTACHARYA SK,BHATTACHARYA MK, DUTTA P et al.: Randomized clinical trial of norfloxacin for shigellosis. Trop. Med. Hyg. (1991) 445:683–687.
   Google Scholar
• ••Original paper on norfloxacin for thetreatment of shigellosis.
   Google Scholar
• BENNIS ML, SALAM MA, HAIDER R, BARZA M: Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin. J. Infect. Dis. (1990) 162:711–716.
   Google Scholar
• ••An original paper on ciprofloxacin for thetreatment of shigellosis.
   Google Scholar
• NIYOGI SK, MITRA U, DUTTA P: Changing pattern of serotypes and antimicrobial susceptibility of Shigella species isolated from children in Calcutta, India. Jpn J. Infect. Dis. (2001) 54:121–122.
   PubMedGoogle Scholar
• SURD, NIYOGI SK, SUR S et al: Multidrug-resistant Shigella dysenteriae type 1: forerunners of a new epidemic strain in eastern India? Emerg. Infect. Dis. (2003) 9(3):404–405.
   Google Scholar
• •A recent paper on drug resistance in Shigella spp.
   Google Scholar
• SARKAR K, GHOSH S, NIYOGI SK et al.: Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet (2003) 361:9359.
   Google Scholar
• ••A recent paper on drug resistance inshigella.
   Google Scholar
• GASSAMA A, SOW PS, FALL F et al.: Ordinary and opportunistic enteropathogens associated with diarrhea in Senegalese adults in relation to human immunodeficiency virus serostatus. Lit. J. Infect. Dis. (2001) 5(4):192–198.
   PubMedGoogle Scholar
• CHANG MJ, DUNKLE LM, VAN RD et al.: Trimethoprim-sulfamethoxazole compared to ampicillin in the treatment of shigellosis. Paediatrics (1977) 59:726.
   PubMedGoogle Scholar
• GOTUZZO E, OBERHELMAN RA, MAGUINA C et al.: Comparison of single dose treatment with norfloxacin and standard 5 day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob. Agents Chemother. (1989) 33(7):1101–1104. Single dose therapy for shigellosis.
   Google Scholar
• BHATTACHARYA SK, BHATTACHARYA MK, DUTTA D et al: Single-dose ciprofloxacin for shigellosis in adults. J. Infect. (1992) 25(1):117–119.
   PubMedGoogle Scholar
• •Single dose therapy for shigellosis.
   Google Scholar
• BENNIS ML, SALAM MA, KHAN WA et al.: Treatment of shigellosis, III. Randomized blinded comparison of one or two dose ciprofloxacin and standard 5 day therapy. Annals Inter Med. (1992) 19:695–698.
   Google Scholar
• ••Original paper on ciprofloxacin for thetreatment of shigellosis.
   Google Scholar
• BHATTACHARYA SK, BHATTACHARYA MK, DUTTA D et al: Double blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediam (1997) 86:319–320.
   PubMed Web of Science ®Google Scholar
• ••The safety of fluoroquinolones in children.
   Google Scholar
• KABIR I, RAHMAN MM, AHMED SM, AKTHER SQ, BUTLER T: Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob. Agents Chemother. (1984) 25(5):643–645.
   PubMedGoogle Scholar
• •Original paper on pivmecillinarn for shigellosis.
   Google Scholar
• BASUALDO W, ARBO A: Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children. Pediam. Infect. Dis. J (2003) 22(4):347–347.
   Google Scholar
• KHAN WA, SEAS C, DHAR U, SALAM MA, BENNISH ML: Treatment of shigellosis: V Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann. Intern. Med. (1997) 126(9):697–703.
   PubMedGoogle Scholar
• •The efficacy of azithromycin.
   Google Scholar
• The treatment of diarrhoea. A manual for physicians and other senior health workers. WHO, Geneva, Switzerland (1995) (WHO/CDR/95.3).
   Google Scholar
• ••An excellent manual on diarrhoeatreatment.
   Google Scholar
• DUPONT HL, HORNICK RB: Adverseeffect of lomotil therapy in shigellosis.J Am. Med. Assoc. (1973) 225:1525.
   Google Scholar